92 results
Page 2 of 5
6-K
EX-99.1
jjd7t
28 Apr 23
GENFIT Announces Publication of Extra-Financial Performance Report 2022
6:00am
6-K
EX-99.1
mrgj7 63gmc6
19 Apr 23
Current report (foreign)
4:10pm
6-K
EX-99.1
qpj605
18 Apr 23
GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
4:10pm
F-3
rc1e 4d8c3sf
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.1
1vv ot0c7zqz8v
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
6-K
EX-99.1
os4sz
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
EX-99.1
shb6rklj226uwf05ir2t
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
EX-99.1
lgsg1ak2qm5 krwg5g8
25 Oct 22
Current report (foreign)
4:10pm
6-K
EX-99.1
2jtklbx7 24mmv
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
EX-99.2
te8fzv52
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
n3j2g xga5t
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
xplww2 cq6s0cp1qyy5
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
EX-99.1
p7s4vrrrups8 qivupv
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
EX-99.1
3egz i6ntlpwc8
8 Jul 22
Current report (foreign)
4:15pm
6-K
EX-99.1
ps4ce232fgn
25 May 22
Current report (foreign)
4:10pm
6-K
EX-99.1
05t3qgk75oz
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
EX-99.1
e8a1jrzic9ba1gw
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm